| P2093 | author name string | Yoshihisa Shimada | |
| P2860 | cites work | Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage | Q48348108 |
| | Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). | Q48375192 |
| | Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial | Q49039293 |
| | Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. | Q53045959 |
| | Oligometastases. | Q55065168 |
| | Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q57051777 |
| | Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q59587212 |
| | NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018 | Q90101749 |
| | Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study | Q91852299 |
| | Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report | Q92526381 |
| | Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review | Q92720875 |
| | Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial | Q93080682 |
| | Tumor metastasis: molecular insights and evolving paradigms | Q29615908 |
| | An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. | Q30828791 |
| | Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial | Q33614301 |
| | Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience. | Q34309262 |
| | Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer | Q36061728 |
| | Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). | Q36278103 |
| | Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis | Q37098182 |
| | Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | Q38409259 |
| | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer | Q38625042 |
| | Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors | Q39362143 |
| | Karnofsky Memorial Lecture. Natural history of small breast cancers | Q40635593 |
| | Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. | Q48229812 |
| P433 | issue | 12 | |
| P304 | page(s) | 5670-5673 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Journal of thoracic disease | Q26841814 |
| P1476 | title | Accelerating the development of therapeutic strategy for oligometastasis | |
| P478 | volume | 11 | |